Toronto Dominion Bank Uro Gen Pharma Ltd. Transaction History
Toronto Dominion Bank
- $58 Billion
- Q2 2025
A detailed history of Toronto Dominion Bank transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Toronto Dominion Bank holds 3,190,510 shares of URGN stock, worth $61.3 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
3,190,510
Previous 1,749,142
82.4%
Holding current value
$61.3 Million
Previous $19.3 Million
125.94%
% of portfolio
0.08%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding URGN
# of Institutions
161Shares Held
39.6MCall Options Held
2.06MPut Options Held
717K-
Rtw Investments, LP New York, NY4.54MShares$87.2 Million0.96% of portfolio
-
Morgan Stanley New York, NY2.48MShares$47.6 Million0.0% of portfolio
-
Jefferies Financial Group Inc. New York, NY2.2MShares$42.2 Million0.27% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$42.1 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.19MShares$42 Million2.32% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $437M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...